Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRevenue (Gross)
Ratios

Abeona Therapeutics (ABEO) Accumulated Depreciation & Amortization (2016 - 2025)

Abeona Therapeutics (ABEO) has 14 years of Accumulated Depreciation & Amortization data on record, last reported at $1.7 million in Q3 2025.

  • For Q3 2025, Accumulated Depreciation & Amortization rose 13.33% year-over-year to $1.7 million; the TTM value through Sep 2025 reached $1.7 million, up 13.33%, while the annual FY2024 figure was $2.0 million, 13.04% down from the prior year.
  • Accumulated Depreciation & Amortization reached $1.7 million in Q3 2025 per ABEO's latest filing, up from $600000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $3.3 million in Q4 2021 and bottomed at $500000.0 in Q1 2024.
  • Average Accumulated Depreciation & Amortization over 5 years is $1.5 million, with a median of $1.5 million recorded in 2024.
  • Peak YoY movement for Accumulated Depreciation & Amortization: plummeted 50.0% in 2022, then surged 66.67% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $3.3 million in 2021, then fell by 6.06% to $3.1 million in 2022, then decreased by 25.81% to $2.3 million in 2023, then decreased by 13.04% to $2.0 million in 2024, then dropped by 15.0% to $1.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $1.7 million in Q3 2025, $600000.0 in Q2 2025, and $500000.0 in Q1 2025.